Welcome to our dedicated page for Core Laboratories news (Ticker: CLB), a resource for investors and traders seeking the latest updates and insights on Core Laboratories stock.
Core Laboratories Inc. reports news on reservoir description and production enhancement services and products for the oil and gas industry. Company updates commonly cover quarterly results, operating income, margins, free cash flow, net debt, leverage, dividends and common-stock repurchases, along with demand trends across conventional, unconventional, onshore and offshore projects.
Core Lab news also includes project and technology developments tied to petroleum reservoir performance, including laboratory analysis, formation evaluation, proprietary tracers such as SpectraStim, and services used by operators in major producing regions. Updates may address acquisitions that expand geological-service capabilities, regional operating disruptions, client project timing and supply-chain conditions that affect energy-service activity.
Core Laboratories (NYSE: CLB) will host its first quarter 2023 conference call on April 27, 2023, at 7:30 a.m. CDT. Key executives, including Chairman and CEO Larry Bruno and CFO Chris Hill, will discuss financial and operational results following the earnings release on April 26, 2023. Participants can access the live call via the company's website and a podcast will be available post-call. Core Laboratories, a leader in reservoir description and production enhancement services, operates over 70 offices across more than 50 countries, providing essential services to optimize petroleum reservoir performance.
Core Laboratories N.V. (NYSE: CLB) reported fourth-quarter 2022 revenue of $128 million, a slight sequential increase, with operating income of $16 million and GAAP EPS of $0.14. Adjusted EPS was $0.20, reflecting a 10% sequential rise. Despite challenges from currency fluctuations and the Russia-Ukraine conflict, free cash flow reached $11.2 million, and net debt fell by $11.7 million. The firm announced its voluntary delisting from Euronext and redomestication to the U.S. for improved efficiencies. Looking ahead, Core anticipates 2023 revenue between $125-$129 million, with a slight decline in Reservoir Description segment revenue due to seasonal patterns.
Core Laboratories N.V. (NYSE: CLB) announced its Board of Directors approved a plan for Redomestication from the Netherlands to the United States, specifically Delaware. This move aims to enhance shareholder value by simplifying corporate structure, improving operational efficiency, and reducing administrative costs. Shareholders will receive one share of Common Stock of Core Lab Delaware for each Common Share owned before the Redomestication. The Company believes this will result in reduced regulatory requirements and a more efficient tax structure. Shareholder approval is required, expected in the second quarter of 2023.
Core Laboratories (NYSE: CLB) will host its fourth quarter 2022 conference call on February 2, 2023, at 7:30 a.m. CST / 2:30 p.m. CET. The discussion will cover financial and operational results, led by Chairman and CEO Larry Bruno, CFO Chris Hill, and SVP Gwen Gresham. An earnings press release will be released after market close on February 1, available on their website. A live webcast can be accessed through www.corelab.com, with a replay lasting 10 days.
Core Laboratories reported a Q3 2022 revenue of $126 million, a 4% sequential increase and 7% year-over-year. Operating income rose by over 25% sequentially. The company's GAAP EPS stood at $0.16, while ex-items EPS was $0.18. Free cash flow reached $3.1 million. Despite currency devaluation impacts, revenues would be higher at constant exchange rates. Core continues to focus on maximizing free cash flow and maintaining a $0.01/b quarterly dividend, with projections for Q4 2022 ranging from
Core Laboratories (NYSE: CLB) will host its third quarter 2022 conference call on October 27, 2022, at 7:30 a.m. CDT (2:30 p.m. CEST). The call will cover financial and operational results, featuring Chairman and CEO Larry Bruno, CFO Chris Hill, and SVP Gwen Gresham. An earnings press release will precede the call, released after market close on October 26. Investors can access the call via webcast at www.corelab.com, with a replay available for 10 days. Core Labs specializes in optimizing petroleum reservoir performance.
Core Laboratories N.V. (CLB) reported Q2 2022 revenue of $120.9 million, marking a 5% sequential increase and a 2% year-over-year growth. Despite the geopolitical impact of the Russia-Ukraine conflict, the company achieved an operating income of $11.7 million and a GAAP EPS of $0.15. Core extended its revolving credit facility through 2026 and announced a $0.01 quarterly dividend. Looking ahead, Q3 revenue is projected to range from $123 million to $129 million, with EPS anticipated between $0.13 and $0.18.
Core Laboratories (CLB) will host its second quarter 2022 conference call on July 28, 2022, at 7:30 a.m. CDT. Key executives including Chairman and CEO Larry Bruno, CFO Chris Hill, and SVP Gwen Gresham will discuss financial and operational outcomes, with an earnings press release available after market close on July 27. The call can be accessed live via the company's website or through a telephone dial-in option by contacting Lena Brennan. Core Laboratories specializes in optimizing petroleum reservoir performance with over 70 offices globally.
Core Laboratories N.V. (NYSE: CLB) has announced the launch of an at-the-market equity offering program allowing the sale of up to $60 million in common shares. The company has partnered with Wells Fargo Securities and BofA Securities as sales agents. The funds will be utilized for general corporate purposes, including product development, capital expenditures, and potential acquisitions. The offering is structured under the existing shelf registration with the SEC. Core Labs retains the right to suspend or terminate the program as needed.
Core Laboratories N.V. (CLB) reported Q1 2022 revenue of $115.3 million, a 6% increase year-over-year. The company faced an operating loss of $400,000 and a GAAP EPS of $(0.04), while ex-items EPS was $0.08. Challenges included COVID-19 impacts and the Russia-Ukraine conflict, which disrupted service revenue. A new CCS strategic alliance with Talos Energy was launched, focusing on carbon emission reduction. The company reduced net debt by $3.3 million and announced a quarterly dividend of $0.01 per share, payable in Q2 2022.